Explore innovations and breakthrough solutions shaping the future of the medical and healthcare industry in the Product Highlights section:
TCI GENE INC
TAIWAN
New at Show
The genetic test by TCI Gene utilizes the gene detection point with the highest genetic pathogenicity. It combines genetic medicine and systems biology to perform comprehensive risk calculations, providing disease risk prediction results and contributing to preventive healthcare.||GREATER VISCOSITY, LONGER DURATION|Utilizing MBI's unique ECHA cross-linking technology|Elasticity > 400 Pa; Viscosity > 50 Pa||HIGH SAFETY, LOW RISK|BDDE < 0.125 ppm|Sourced from non-animal origins||SUPERIOR QUALITY|In compliance with ISO13485 & ISO17665 & Class 100|20 stages of incoming material inspection and product factory testing|
